Brooge Energy LTD Signs Offtake Agreement with Super Major Oil Company
NEW YORK, May 04, 2020 (GLOBE NEWSWIRE) — Brooge Energy Limited (“Brooge Energy” or the “Company”) (NASDAQ: BROG), a midstream […]
Green Plains Partners Reports First Quarter 2020 Financial Results
Results for the First Quarter of 2020Net income of $10.4 million, or $0.44 per common unitAdjusted EBITDA of $13.4 million […]
OSS to Host AI at the Edge Webinar with Leaders from NVIDIA and Marvell
ESCONDIDO, Calif., May 04, 2020 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (Nasdaq: OSS), a leader in specialized high-performance edge […]
Sharps Compliance Announces Appointment of Transportation and Logistics Executive Jack Holmes to Board of Directors
HOUSTON, May 04, 2020 (GLOBE NEWSWIRE) — Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national […]
ChemoCentryx to Hold First Quarter 2020 Financial Results Conference Call on Monday, May 11, 2020
MOUNTAIN VIEW, Calif., May 04, 2020 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s first quarter […]
Bellerophon Therapeutics to Participate in COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference
WARREN, N.J., May 04, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing […]
Capitala Finance Corp. Receives “Green Light” from Small Business Administration for Fifth SBIC License
CHARLOTTE, N.C., May 04, 2020 (GLOBE NEWSWIRE) — Capitala Group (“Capitala”), a leading provider of capital to lower middle market […]
PDS Biotechnology Announces Conference Call and Webcast for First Quarter 2020 Financial Results
FLORHAM PARK, N.J., May 04, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel […]
Green Plains Reports First Quarter 2020 Financial Results
Results for the First Quarter of 2020:Net loss attributable to the company of $16.4 million, or $(0.47) per diluted share […]
GeneTx and Ultragenyx Announce GTX-102 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome
SARASOTA, Fla. and NOVATO, Calif., May 04, 2020 (GLOBE NEWSWIRE) — GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), […]
